Invest in Silverback Therapeutics Inc on Stash

Silverback Therapeutics, Inc., is a clinical-stage biopharmaceutical company.

To buy fractional shares

of Silverback Therapeutics Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Silverback Therapeutics Inc

Ticker: SBTX

Silverback Therapeutics Inc

$3.10

+5.44%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

SBTX Performance Breakdown

Share Price

$3.10

Today's change

-4.32%

Year to date change (YTD)

-54.01%

Dividend yield

N/A

Last dividend paid

N/A

Last dividend pay date

N/A

About SBTX

Silverback Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on ImmunoTAC technology platform to develop therapeutics for the treatment of cancer, chronic viral infections, and other diseases. Its ImmunoTAC platform includes three components, such as Antigen binding domain, Linker-payload, and Fc region. Its lead product candidate, SBT6050, is comprised of a Toll-like receptor 8 (TLR8) agonist linker-payload conjugated to a human epidermal growth factor receptor 2 (HER2)-directed monoclonal antibody that targets tumors including certain breast, gastric and non-small cell lung cancers. Its second product candidate, SBT6290, is comprised of a TLR8 agonist as a payload. SBT6290 is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4. Its third TLR8 program, SBT8230, is comprised of a TLR8 linker-payload conjugated to an ASGR1 monoclonal antibody that is for the treatment of chronic hepatitis B virus infection (cHBV).

Silverback Therapeutics Inc Stock Ticker

SBTX

For more information

https://silverbacktx.com/

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Certain companies are volatile.

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,8 recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.1

Learn how to invest

Get professional advice and education at every step.

How to buy Silverback Therapeutics Inc stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Stash offers three subscription plans: Stash Beginner, Stash Growth, and Stash+. Our Beginner plan starts at just $1 per month.

Once your market order of Silverback Therapeutics Inc stock is complete, you'll officially be a shareholder of Silverback Therapeutics Inc!

Invest in Silverback Therapeutics Inc on Stash

Silverback Therapeutics, Inc., is a clinical-stage biopharmaceutical company.

To buy fractional shares

of Silverback Therapeutics Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Subscribe to The Wallet!

Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!

By using this website you agree to our Terms of Use and Privacy Policy.

Ready to start
building wealth?

By using this website you agree to our Terms of Use and Privacy Policy.